Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Boyer

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Emerging Microbes & Infections|November 5, 2024
COVID-19 vaccination modified the effect of nirmatrelvir-ritonavir on post-acute mortality and rehospitalization: a retrospective cohort studyHuwen Wang, Yuchen Wei, Guozhang Lin, et al.
Emerging Microbes & Infections|February 18, 2025
Effectiveness of nirmatrelvir/ritonavir and molnupiravir on post-COVID-19 outcomes among outpatients: a target trial emulation investigationYuchen Wei, Christopher Boyer, Katherine Min Jia, et al.
The Lancet. Rheumatology|November 11, 2024
Association of nirmatrelvir-ritonavir with post-acute sequelae and mortality among patients who are immunocompromised with COVID-19 in Hong Kong: a retrospective cohort studyGuozhang Lin, Yuchen Wei, Huwen Wang, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 9, 2026
Association between early SARS-CoV-2 viral rebound and post-COVID conditions among immunocompromised patients: cohort studyGuozhang Lin, Yuchen Wei, Carlos King Ho Wong, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Emerging Microbes & Infections|November 5, 2024
COVID-19 vaccination modified the effect of nirmatrelvir-ritonavir on post-acute mortality and rehospitalization: a retrospective cohort studyHuwen Wang, Yuchen Wei, Guozhang Lin, et al.
Emerging Microbes & Infections|February 18, 2025
Effectiveness of nirmatrelvir/ritonavir and molnupiravir on post-COVID-19 outcomes among outpatients: a target trial emulation investigationYuchen Wei, Christopher Boyer, Katherine Min Jia, et al.
The Lancet. Rheumatology|November 11, 2024
Association of nirmatrelvir-ritonavir with post-acute sequelae and mortality among patients who are immunocompromised with COVID-19 in Hong Kong: a retrospective cohort studyGuozhang Lin, Yuchen Wei, Huwen Wang, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 9, 2026
Association between early SARS-CoV-2 viral rebound and post-COVID conditions among immunocompromised patients: cohort studyGuozhang Lin, Yuchen Wei, Carlos King Ho Wong, et al.
Pageof 4